Tango Therapeutics Inc (TNGX)

EBITDA Margin

-226.46%

TTM · Period ending:

TNGX logo

TNGX EBITDA Margin

Latest reported-226.46%
TNGX TTM EBITDA Margin (-671.59% → -226.46%)
High-resolution chart · PNG

TNGX ebitda margin history

Trailing twelve months (TTM). Each value covers four complete reported quarters.

Tango Therapeutics Inc EBITDA Margin — Trailing twelve months (TTM)
Period endingEBITDA Margin
-226.4611%
-184.4803%
-159.1899%
-147.3436%
-588.159%
-316.084%
-303.2921%
-278.197%
-267.7762%
-292.8046%
-271.5662%
-260.0448%
-310.2567%
-438.4832%
-428.4553%
-412.5305%
-375.9903%
-192.5551%
-154.0036%
-108.995%
-229.1538%
-593.119%
-671.5872%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.